Show Stocks and Investing Publications • Thu, November 18, 2021
• Fri, November 19, 2021
Vamil Divan Maintained (BHVN) at Strong Buy with Increased Target to $144 on, Nov 18th, 2021
tained-bhvn-at-strong-buy-with-increased-target-to-144-on-nov-18th-2021.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAIVamil Divan of Mizuho, Maintained "Biohaven Ltd." (BHVN) at Strong Buy with Increased Target from $135 to $144 on, Nov 18th, 2021.
Vamil has made no other calls on BHVN in the last 4 months.
There are 7 other peers that have a rating on BHVN. Out of the 7 peers that are also analyzing BHVN, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Tuesday, October 19th, 2021
- Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021
These are the ratings of the 5 analyists that currently disagree with Vamil
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, October 6th, 2021
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $160 on, Wednesday, October 6th, 2021
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $156 on, Tuesday, October 5th, 2021
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021
Like: 👍